Ignite Creation Date:
2024-05-05 @ 6:32 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00509405
Status:
COMPLETED
Last Update Posted:
2012-04-24
First Post:
2007-07-30
Brief Title:
Effect of Neutralization of Endogenous Acid Production on BMD and Bone Microarchitectural
Sponsor:
Kantonsspital Baselland Bruderholz
Organization:
Kantonsspital Baselland Bruderholz
Study Overview
Official Title:
Effect of Neutralization of Endogenous Acid Production on Bone Mineral Density and Microarchitectural Composition of Bone in Humans
Status:
COMPLETED
Status Verified Date:
2012-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hypothesis Neutralization of acid production induced by the Western diet with oral administration of potassium citrate increases bone mineral density and bone mass as well as skeletal muscle mass and strength in elderly people 65y
Detailed Description:
We will perform a prospective randomized placebo-controlled trial evaluating the effect of K citrate on bone mineral density microarchitectural composition of bonenutritional parameters lean body mass parameters of skeletal muscle mass and strength 24h and exercise induced blood pressure changes in otherwise healthy elderly ambulatory subjects of both genders
Potassium citrate 60 mEq is supplied as tablets with a wax matrix 10 mEq of citrate per tablet and ingested in three dosesday All subjects will receive daily oral 500 mg of calcium and 400 IU of vitamin D to ensure adequate calcium and vitamin D supply
Potassium citrate 60 mEq is supplied as tablets with a wax matrix 10 mEq of citrate per tablet and ingested in three dosesday All subjects will receive daily oral 500 mg of calcium and 400 IU of vitamin D to ensure adequate calcium and vitamin D supply
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NFP 53 4053-110259 | None | None | None |